Cargando…
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is malignancies of the biliary duct system and constitutes approximately 10%-20% of all primary liver cancers. Tumor mutation burden (TMB) is a useful biomarker across many cancer types for the identification of patients who will benefit from immunot...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790456/ https://www.ncbi.nlm.nih.gov/pubmed/35127895 http://dx.doi.org/10.12998/wjcc.v10.i3.790 |